Advanced Therapy Medicinal Products CDMO Market (2024 - 2030) Size, Share & Trends Analysis Report By Product (Gene Therapy, Cell Therapy), By Phase, By Indication, By Region, And Segment Forecasts

Market Segmentation

• Advanced Therapy Medicinal Products CDMO Product Outlook (USD Million, 2018 - 2030)
  • Gene Therapy
  • Cell Therapy
  • Tissue Engineered
  • Others
• Advanced Therapy Medicinal Products CDMO Phase Outlook (USD Million, 2018 - 2030)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
• Advanced Therapy Medicinal Products CDMO Indication Outlook (USD Million, 2018 - 2030)
  • Oncology
  • Cardiology
  • Central nervous system
  • Musculoskeletal
  • Infectious disease
  • Dermatology
  • Endocrine, metabolic, genetic
  • Immunology & inflammation
  • Ophthalmology
  • Hematology
  • Gastroenterology
  • Others
• Advanced Therapy Medicinal Products CDMO Regional Outlook (USD Million, 2018 - 2030)
  • North America
    • North America Advanced Therapy Medicinal Products CDMO Market, By Product
      • Gene Therapy
      • Cell Therapy
      • Tissue Engineered
      • Others
    • North America Advanced Therapy Medicinal Products CDMO Market, By Phase
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
    • North America Advanced Therapy Medicinal Products CDMO Market, By Indication
      • Oncology
      • Cardiology
      • Central nervous system
      • Musculoskeletal
      • Infectious disease
      • Dermatology
      • Endocrine, metabolic, genetic
      • Immunology & inflammation
      • Ophthalmology
      • Hematology
      • Gastroenterology
      • Others
    • U.S.
      • U.S. Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • U.S. Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • U.S. Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central Nervous System
        • Musculoskeletal
        • Infectious Disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Hematology
        • Gastroenterology
        • Others
    • Canada
      • Canada Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Canada Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Canada Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
  • Europe
    • Europe Advanced Therapy Medicinal Products CDMO Market, By Product
      • Gene Therapy
      • Cell Therapy
      • Tissue Engineered
      • Others
    • Europe Advanced Therapy Medicinal Products CDMO Market, By Phase
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
    • Europe Advanced Therapy Medicinal Products CDMO Market, By Indication
      • Oncology
      • Cardiology
      • Central nervous system
      • Musculoskeletal
      • Infectious disease
      • Dermatology
      • Endocrine, metabolic, genetic
      • Immunology & inflammation
      • Ophthalmology
      • Hematology
      • Gastroenterology
      • Others
    • UK
      • UK Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • UK Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • UK Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • Germany
      • Germany Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Germany Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Germany Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • France
      • France Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • France Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • France Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • Italy
      • Italy Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Italy Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Italy Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • Spain
      • Spain Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Spain Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Spain Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • Sweden
      • Sweden Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Sweden Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Sweden Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • Norway
      • Norway Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Norway Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Norway Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • Denmark
      • Denmark Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Denmark Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Denmark Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
  • Asia Pacific
    • Asia Pacific Advanced Therapy Medicinal Products CDMO Market, By Product
      • Gene Therapy
      • Cell Therapy
      • Tissue Engineered
      • Others
    • Asia Pacific Advanced Therapy Medicinal Products CDMO Market, By Phase
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
    • Asia Pacific Advanced Therapy Medicinal Products CDMO Market, By Indication
      • Oncology
      • Cardiology
      • Central nervous system
      • Musculoskeletal
      • Infectious disease
      • Dermatology
      • Endocrine, metabolic, genetic
      • Immunology & inflammation
      • Ophthalmology
      • Hematology
      • Gastroenterology
      • Others
    • Japan
      • Japan Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Japan Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Japan Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • China
      • China Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • China Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • China Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • India
      • India Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • India Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • India Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • Australia
      • Australia Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Australia Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Australia Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • South Korea
      • South Korea Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • South Korea Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • South Korea Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • Thailand
      • Thailand Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Thailand Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Thailand Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
  • Latin America
    • Latin America Advanced Therapy Medicinal Products CDMO Market, By Product
      • Gene Therapy
      • Cell Therapy
      • Tissue Engineered
      • Others
    • Latin America Advanced Therapy Medicinal Products CDMO Market, By Phase
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
    • Latin America Advanced Therapy Medicinal Products CDMO Market, By Indication
      • Oncology
      • Cardiology
      • Central nervous system
      • Musculoskeletal
      • Infectious disease
      • Dermatology
      • Endocrine, metabolic, genetic
      • Immunology & inflammation
      • Ophthalmology
      • Hematology
      • Gastroenterology
      • Others
    • Brazil
      • Brazil Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Brazil Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Brazil Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • Mexico
      • Mexico Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Mexico Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Mexico Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • Argentina
      • Argentina Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Argentina Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Argentina Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
  • MEA
    • MEA Advanced Therapy Medicinal Products CDMO Market, By Product
      • Gene Therapy
      • Cell Therapy
      • Tissue Engineered
      • Others
    • MEA Advanced Therapy Medicinal Products CDMO Market, By Phase
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
    • MEA Advanced Therapy Medicinal Products CDMO Market, By Indication
      • Oncology
      • Cardiology
      • Central nervous system
      • Musculoskeletal
      • Infectious disease
      • Dermatology
      • Endocrine, metabolic, genetic
      • Immunology & inflammation
      • Ophthalmology
      • Hematology
      • Gastroenterology
      • Others
    • South Africa
      • South Africa Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • South Africa Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • South Africa Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • Saudi Arabia
      • Saudi Arabia Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Saudi Arabia Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Saudi Arabia Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • UAE
      • UAE Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • UAE Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • UAE Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others
    • Kuwait
      • Kuwait Advanced Therapy Medicinal Products CDMOMarket, By Product
        • Gene Therapy
        • Cell Therapy
        • Tissue Engineered
        • Others
      • Kuwait Advanced Therapy Medicinal Products CDMOMarket, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Kuwait Advanced Therapy Medicinal Products CDMOMarket, By Indication
        • Oncology
        • Cardiology
        • Central nervous system
        • Musculoskeletal
        • Infectious disease
        • Dermatology
        • Endocrine, metabolic, genetic
        • Immunology & inflammation
        • Ophthalmology
        • Hematology
        • Gastroenterology
        • Others

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance